DOCSLIB.ORG

The 5Th Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO 2017)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The 5Th Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO 2017) The 5th Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO 2017) Date: November 30 (Thu)-December 2 (Sat), 2017 Venue: Otemachi Sankei Plaza (Tokyo) Congress President: Daisuke Aoki, M.D., Ph.D (Professor and Chairman, Department of Obstetrics and Gynecology, Keio University School of Medicine) Program & Abstracts Contents Welcome Message …………………………………………………………………… 3 Organization …………………………………………………………………………… 4 Meeting Information ………………………………………………………………… 5 Congress App ………………………………………………………………………… 7 General Information ………………………………………………………………… 8 Instructions Regarding Scientific Program ……………………………………… 10 Access to Venues …………………………………………………………………… 12 Floor Map ……………………………………………………………………………… 13 Access to Banquet …………………………………………………………………… 14 Time Table …………………………………………………………………………… 15 Program ………………………………………………………………………………… 19 [Day 1] November 30 (Thu.) …………………………………………………… 21 [Day 1] Poster Exhibition ……………………………………………………… 29 [Day 2] December 1 (Fri.) ……………………………………………………… 41 [Day 2] Poster Exhibition ……………………………………………………… 52 [Day 3] December 2 (Sat.) ……………………………………………………… 63 Film Exhibition Expert Techniques in Gynecologic Surgery …………………………… 68 Surgical Film Exhibition …………………………………………………… 69 Abstracts ……………………………………………………………………………… 71 Chairpersons Index ………………………………………………………………… 309 Authors Index ……………………………………………………………………… 315 2 Welcome Message The 5th ASGO Meeting will be held at Otemachi Sankei Plaza in Tokyo. Following the 1st Council Meet- ing held in Seoul, Korea in June 2009, the 1st Biennial Meeting was held in Tokyo, Japan in 2009. Since then, the meetings have been alternately held in Korea and Japan. The first meeting lasted one day, but as time has passed, the meeting length has increased: this meeting is also scheduled to last three days. The Asian Society of Gynecologic Oncology (ASGO) is an organization comprised of researchers in major Asian countries that is focused on the research, prevention, and treatment of gynecological cancer. It cur- rently has members from more than 10 countries in Asia. The biennial meetings, in which the top runners of each Asian country gather, have previously produced a number of results, which have been presented around the world. This trend will continue in the 5th Biennial Meeting, and we expect even more highly precise research results to be presented. Furthermore, we will continue to enrich our research on gyneco- logic tumors and education programs for young researchers who support medical care. The venue for this meeting is located in Otemachi, Tokyo, which can be easily accessed from two air- ports, Narita International Airport and Tokyo International Airport (Haneda Airport). Moreover, the meet- ing will be held at the end of November to early December, a season in which the autumn leaves can be viewed in Japan. Tokyo Metropolis, the location of the meeting, is one of the most preeminent metropolitan areas in the world, also full of large parks and green spaces; participants can enjoy the beautiful autumn leaves of the Imperial Palace in the vicinity of the Otemachi venue. Furthermore, located a little further from the venue is Ginza, one of the most exciting areas in Tokyo. Participants can also enjoy the beautiful areas reminiscent of ancient Edo such as Nihonbashi and Asakusa while enjoying Edo food culture. During the event, we plan to hold various events such as a chance for participants to explore the culture of Tokyo Metropolis and its historical predecessor Edo. We look forward to seeing all of you there. Ikuo Konishi, M.D., Ph.D. Daisuke Aoki, M.D., Ph.D. President, Asian Society of Gynecologic Oncology Congress President, (ASGO) The 5th Biennial Meeting of ASGO 3 Organization Congress President Daisuke Aoki (Japan) ASGO Council Members Andri Andrijono (Indonesia) Nobuo Yaegashi (Japan) Chunling Chen (China) Sarikapan Wilailak (Thailand) Daisuke Aoki (Japan) Seung Cheol Kim (Korea) Duk-Soo Bae (Korea) Shingo Fujii (Japan) Efrén Domingo (Philippines) Soon-Beom Kang (Korea) Hee-Sug Ryu (Korea) Suresh Kumarasamy (Malaysia) Ikuo Konishi (Japan) Toshiharu Kamura (Japan) Jae-Weon Kim (Korea) Uma Devi (India) Joo-Hyun Nam (Korea) Yin Nin Chia (Singapore) Kimio Ushijima (Japan) Yuen Sheung Hextan Ngan (Hong Kong) Kung-Liahng Wang (Taiwan) Local Organizing Committee Japan Daisuke Aoki Hiroaki Kobayashi Kazuhiko Inou Kei Kawana Kenichiro Morishige Kiichiro Noda Masaki Mandai Nao Suzuki Satoru Nagase Toyomi Sato Tsuyoshi Saito 4 Meeting Information Date and Venue Date: November 30 (Thu) - December 2 (Sat), 2017 Venue: Otemachi Sankei Plaza 1 - 7 - 2, Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan Tel: +81 - (0)3 - 3273 - 2230 FAX: +81 - (0)3 - 3270 - 3039 URL: http://www.s-plaza.com/en/access/ Contact Organizing Secretariat ASGO 2017 c/o MA Convention Consulting, Inc. Kojimachi Parkside Building 402, 4 - 7 Kojimachi, Chiyoda-ku, Tokyo 102-0083, Japan TEL: 81 - (0)3 - 5275 - 1191/FAX: 81 - (0)3 - 5275 - 1192 E-mail: [email protected] Official Website http://asgo2017tokyo.umin.jp/index.html Registration Early-bird Registration 35,000 JPY (on/before November 23 (Thu), 2017) On-site Registration 40,000 JPY Registration fee include admissions for the following: - All scientific programs/exhibitions - Meeting publications - The banquet which will be held on December 1 (Fri) Registration Desk: Foyer, 3F Opening Hours 15 : 00 - 18 : 30, November 29 (Wed) 8 : 00 - 19 : 00, November 30 (Thu) 7 : 30 - 19 : 00, December 1 (Fri) 7 : 30 - 13 : 30, December 2 (Sat) On-site Registration For on-site registration, payment must be made in Japanese yen by either credit card or cash. Lunch Lunch boxes will be provided free of charge at all Industrial Lunchtime Seminars. Lunch boxes will be provided at the entrance of each Industrial Lunchtime Seminars room on a first-come, first-served basis. Social Event Banquet Date and Time: 19 : 00 - 21 : 00, December 1 (Fri) Venue: Royal Hall, Royal Park Hotel 3F, 2 - 1 - 1 Nihonbashi Kakigara-cho, Chuo-ku, Tokyo 103-8520, Japan *Registrants are welcome to join the welcome reception with free of charge. 5 There is complimentary Shuttle from the Congress venue to the Banquet venue. Please ask the registration desk for more detail. Certification You can get certificate when you attend the congress. 6 Congress App Get the ASGO 2017 Congress App for your smartphone As one of the services for participants, abstract search and/or schedule registry service is offered. By searching the sessions you would like to attend and registering it to your schedule, you may create your original schedule during the congress very easily. Download the ASGO 2017 Congress App To download the Congress App, search ASGO 2017 in your App store/ Google Play store. Access Code: asgo2017 The app is available for iOS and Android devices. 7 General Information Passport And Visa To visit Japan, you must have a valid passport. A visa is required for citizens of countries that do not have visa-exempt agreements with Japan. Please contact the nearest Japanese Embassy or Consulate for visa requirements. Duty Free Import Duty-free/Tax-free Allowance Item Allowance (for an adult) Remarks Alcoholic Beverages 3 bottles A bottle contains approximately 760cc Cigars 100 cigars 400 Japan-made cigarettes If a visitor brings in more than one kind of Tobacco Cigarettes 400 foreign-made cigarettes tobacco product, the total allowance is 500 Products grams. Other kinds of 500 grams tobacco Perfume 2 ounces The total overseas market value of all articles other than the above items must be under 200,000yen. Any item whose overseas market value is under 10,000yen is free of duty and/or Others 200,000yen tax and is not included in the calculation of the total overseas market value of all articles. There is no duty-free allowance for articles having a market value of more than 200,000yen each or each set. (Notes) *1 Commodities and commercial samples are subject to duty and/or tax since they are not regarded as being for personal use. *2 In the case of applying duty-free allowance for rice, please submit a “Report for the Import of Rice” to the Local Food Office or other competent organization, then submit one of the copies which are returned to you to the Customs Office. *3 For residents, the duty-free allowances for tobacco products are half of the amounts listed above. Insurance The organizer cannot accept responsibility for accidents that might occur. Delegates are encouraged to purchase travel insurance before leaving their home country. Insurance plans typically cover accidental loss of belongings, medical costs in case of injury or illness, and other possible risks of international travel. 8 Climate Average Temperature in Tokyo during conference: November December 14.4℃ 9.2℃ Currency Exchange Only Japanese yen (JPY) is acceptable at regular stores and restaurants. Certain foreign currencies may be accepted at a limited number of hotels, restaurants and souvenir shops. You can buy YEN at foreign exchange banks and other authorized money exchangers on presentation of your passport. Credit Cards VISA, MasterCard, Diners Club, and American Express are widely accepted at hotels, department stores, shops, restaurants and nightclubs. Tipping In Japan, tips are not necessary anywhere, even at hotels and restaurants. Electricity Electric voltage is uniformly 100 volts, AC, throughout Japan, but with two different cycles: 50 in Tokyo, and 60 in Western Japan * Leading hotels in major cities have two outlets of 100 and 220 volts but their sockets usually accept a two- leg plug only. 9 Instructions
Load more

Recommended publications
  • YG Entertainment (122870 KQ) [Summary] Korea’S 2019 Media/Entertainment Competitiveness
    2019 Outlook Media platform/Content Most favorable environment in history; focus on PR.I.C.E Analyst Jay Park +822-3774-1652 [email protected] Contents [Summary] 3 I. Outlook by segment 4 II. Medium-/long-term outlook 10 III. Key points to watch 12 IV. Global peer group (valuation) , Investment strategy 21 V. Top Picks 23 Studio Dragon (253450 KQ) YG Entertainment (122870 KQ) [Summary] Korea’s 2019 media/entertainment competitiveness Shares to be driven by content sales (p, US$m) (%) Media/content business model focused on direct sales 500 40 FTSE KOREA MEDIA indx (L) Key words: Global platforms, geopolitics, licensing fees, Domestic ad market growth (R, YoY) blockbusters, investments, leverage Broadcast content export growth (R, YoY) 400 30 Media/content business model focused on ads Key words: Domestic market, ad trends, seasonality, politics/sports 300 20 200 10 100 0 OTT export expansion in 2016-18 Chinese market lull 0 OTT export expansion in 2019F + Chinese market recovery -10 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 Note: 2017 exports are based on KOCCA’s estimates; 2018 exports based on our estimates Source: Thomson Reuters, KOCCA, Cheil Worldwide, Mirae Asset Daewoo Research 3| 2019 Outlook [Media platform/Content] Mirae Asset Daewoo Research I. Outlook by segment: Media ads Ad market: Mobile and • We expect the domestic ad market to grow 3% YoY (similar to GDP growth) to W11.3tr, amid the absence of large- generalist/cable TV scale sporting events. • We forecast positive growth across all segments (except print ads), with mobile, generalist channels and cable TV channel ads are growing channels likely to drive growth.
    [Show full text]
  • News from Hope College, Volume 14.1: August, 1982 Hope College
    Hope College Hope College Digital Commons News from Hope College Hope College Publications 1982 News from Hope College, Volume 14.1: August, 1982 Hope College Follow this and additional works at: https://digitalcommons.hope.edu/news_from_hope_college Part of the Archival Science Commons Recommended Citation Hope College, "News from Hope College, Volume 14.1: August, 1982" (1982). News from Hope College. 44. https://digitalcommons.hope.edu/news_from_hope_college/44 This Book is brought to you for free and open access by the Hope College Publications at Hope College Digital Commons. It has been accepted for inclusion in News from Hope College by an authorized administrator of Hope College Digital Commons. For more information, please contact [email protected]. :V news from fi* HOPE COLLEGE AUGUST, 1982 PUBLISHED BY THE HOPE COLLEGE OFFICE OF INFORMATION SERVICES, HOLLAND, MICHIGAN Construction Begins on Administrative Quarters Construction of facilitiesto replace the during the 1982-83 academic year with the Hope College central administrativebuilding exception of the theatre, bookstore and word destroyed by fire two years ago has begun. processing-mail service areas. Other admin- Van Raalte Hall, a 78-year-old structurein istrative areas will be relocatedin temporary the center of the Hope campus, was destroyed quarters throughoutthe campus. by fire on April 28, 1980. ‘Since that time The nearby Carnegie-Schoutengymnasium administrativeoffices have been located in was razed during July. The 76-year-old build- locationsthroughout the campus, primarily ing has not been used for physical education the DeWitt Center. purposes since the college opened its Dow In February, 1981, the college's Board of Center in 1977.
    [Show full text]
  • Dear Participants of the 5Th World Congress on Alternatives And
    Abstracts001-Edi 24.07.2005 12:17 Uhr Seite 1 EDITORIAL Dear Participants of the 5th World Congress on Alternatives and Animal Use in the Life Sciences, The abstract book contains 614 abstracts of the plenary lectures of 272 oral presentations and 342 posters to be presented at the 5th World Congress on Alternatives in August 2005 in Berlin, Germany. The programme and the abstract book allow you to make your best selection of presentations among seven themes, which will be discussed in 29 sessions, 15 workshops and in the poster sessions. Usually, the first author of an abstract is slotted to give the oral presentation or to be present during the poster session to discuss your comments and questions. Otherwise, the presenting author is marked with an asterisk (*). We hope that you will find the abstracts particularly helpful to set priorities when two or more sessions are scheduled at the same time. In case you do not manage to attend a session or to meet an author, the contact addresses are given for each contributor. It is obvious from the list of sponsors, the programme and from the number of abstracts submitted that the most important topic of the 5th World Congress will be in vitro testing of cosmetic ingredients, in particular acute local toxicity testing. More abstracts have been submitted to sessions and workshops of Theme 5 “Safety testing, validation and risk assessment” than to any of the other themes. Moreover, more than 60 abstracts have been submitted to session 5.4 “Development and validation of alternatives for dermal toxicity testing”.
    [Show full text]
  • Commencement
    Commencement May 2017 Iowa City, Iowa Cover Design: The cover design represents the gold and topaz medallion worn by The University of Iowa president at formal academic ceremonies on campus. The medallion was designed and made by Karen Cantine as part of the work for her M.A. conferred August 4, 1965. 2 The University of Iowa Commencement Ceremonies Thursday, May 11, 2017 College of Pharmacy Hancher Auditorium 10:00 a.m. Friday, May 12, 2017 Tippie MBA Program Hancher Auditorium 9:00 a.m. College of Law Hancher Auditorium 2:00 p.m. Carver College of Medicine M.D./M.M.E. Hancher Auditorium 6:30 p.m. Graduate College Carver-Hawkeye Arena 7:00 p.m. Saturday May 13, 2017 Nursing Hancher Auditorium 9:00 a.m. Liberal Arts and Sciences Carver-Hawkeye Arena 9:00 a.m. Liberal Arts and Sciences University College Carver-Hawkeye Arena 1:00 p.m. Tippie College of Business Carver-Hawkeye Arena 5:00 p.m. Carver College of Medicine B.S. Hancher Auditorium 6:30 p.m. Sunday May 14, 2017 College of Engineering Carver-Hawkeye Arena 12:00 p.m. 3 4 Table of Contents University Leaders ...............................................................................................................................................................7 Honorary Degrees Awarded by the University of Iowa ...............................................................................................9 Candidates for Degrees, May 2017 ................................................................................................................................. 11 College
    [Show full text]
  • Microrna Profiles Involved in Trifluridine Resistance
    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 32), pp: 53017-53027 Research Paper MicroRNA profiles involved in trifluridine resistance Kenta Tsunekuni1,2,3,*, Masamitsu Konno1,4,*, Ayumu Asai1,2,4, Jun Koseki2, Takashi Kobunai3, Teiji Takechi3, Yuichiro Doki1, Masaki Mori1 and Hideshi Ishii1,2 1Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan 2Department of Medical Data Science, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan 3Translational Research Laboratory, Taiho Pharmaceutical Co, Ltd, Tokushima City, Tokushima, 771-0194, Japan 4Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan *These authors contributed equally to this work Correspondence to: Masaki Mori, email: [email protected] Hideshi Ishii, email: [email protected] Keywords: colorectal cancer, trifluridine, 5-fluorouracil, let-7d-5p, drug resistance Received: March 28, 2017 Accepted: May 09, 2017 Published: May 23, 2017 Copyright: Tsunekuni et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Trifluridine (FTD) is a key component of the novel oral antitumor drug trifluridine/tipiracil, which is approved for the treatment of patients with metastatic colorectal cancer refractory to standard chemotherapies. A microRNA analysis of three colorectal cell lines was conducted to investigate causes of FTD resistance. Drug resistant sublines of DLD-1, HCT-116, and RKO cells were developed by continuous administration of increasing doses of FTD for 5 months.
    [Show full text]
  • Taiho Pharmaceutical
    Generating Innovation with Japan: BC 2021 - HealthTech Taiho Pharmaceutical Robert Tam, Director, Market Access March 9, 2021 Corporate Philosophy Company Profile Taiho Pharmaceutical, co. ltd ● Established June, 1963 ● Head Quarter Tokyo ● President & Representative Director Masayuki Kobayashi ● Employees 2,315 ● NET Sales ¥138.9B (US$1.3B) Others 8% Others Discovery CHC 9% Oncology 68% Clinical･MA Dermatology 5% CHC CMC Net Sales Employees Allergy n=2,315 10% ¥ 138.9 B Production Drug Sales (as of January 2019) QA 2 Offices and Facilities ● Head Office/Tokyo ● Branch Offices: 15 ・ Headquarter functions ・ Ethical drug: 15 ・ Clinical development ・ Consumer: 7 ・ QA ・ Medical affairs ・ Marketing Pharmaceutical value chain Drug Discovery Drug Development Manufacturing Sales & Marketing ● Research Institute: 2 ● Plants: 4 Tsukuba Saitama (API) Tokushima (Products) ・ Target identification U.S. Inspection U.S. Inspection European authorities Inspection ・ Lead optimization European authorities Inspection Tokushima Kitajima (Products) Inuyama (API) ・ Pre-clinical studies U.S. Inspection European authorities Inspection ・ CMC development OSDrC Tec 3 3 Taiho Subsidiary Companies Taiho Pharmaceutical Co., Ltd. Global Headquarters Taiho Pharmaceutical Taiho Oncology Europe, GmbH of Beijing Co., Ltd. Taiho Pharma Canada, Inc. Development, Sales Promotion/Clinical Sales Taiho Ventures LLC. Venture Capital Taiho Innovations LLC. Taiho Oncology, Inc. Venture Capital Sales/Clinical Okayama -Taiho Taiho Pharma Pharmaceutical Co., Ltd. Singapore Pte., Ltd. Research / Clinical / Sales Production / Sales 4 4 Overview of Otsuka Group ● Otsuka Group Profile 189 companies (162 subsidiaries and 26 affiliates , plus 1 company (Otsuka Holdings itself)) About 47,000 employees Global network: JP, Asia, MEA, Oceania, EU, NA, LA （as of December 31, 2018） ● Structure of Group Capital Otsuka Holdings Co., Ltd.
    [Show full text]
  • Health Canada Approves Inqovi® (Decitabine And
    HEALTH CANADA APPROVES INQOVI® (DECITABINE AND CEDAZURIDINE) ORAL THERAPY FOR TWO TYPES OF BLOOD CANCERS, MDS AND CMML • Oral drug can be taken at home, which may enable some patients to avoid some hospital visits • Treatment can induce complete remission and reduce blood transfusion needs for patientsi OAKVILLE, ON, OCTOBER 8, 2020 – Taiho Pharma Canada, Inc., the Canadian subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announces that Health Canada approved INQOVI® as the first and only orally administered hypomethylating agent for the treatment of adults with intermediate-1, intermediate-2 and high-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML),ii two blood malignancies. INQOVI was developed by Astex Pharmaceuticals, a sister company of Taiho and will be available in Canada. “INQOVI offers selected MDS patients an effective oral treatment alternative to the current standard 7 days of subcutaneous injections administered in a cancer centre every month,” says Dr. Rena Buckstein, Hematologist Oncologist at the Odette Cancer Centre at Sunnybrook Health Sciences Centre, Toronto, Ontario. “Having an oral option is very important for patients who cannot travel and is particularly significant during the COVID-19 pandemic when we try to minimize hospital visits to protect patients and medical staff.” “Canadian oncologists and patients were involved in the clinical development program for INQOVI with several clinical study sites,” said Dr. Mohammad Azab, President and Chief Medical Officer of Astex Pharmaceuticals. “We are thrilled that INQOVI is now available for healthcare professionals to prescribe to their patients across Canada living with MDS and CMML.” About MDS & CMML Myelodysplastic syndromes (MDS) are a group of diseases in which the bone marrow does not make enough healthy mature blood cells.
    [Show full text]
  • Company Pr0file 2021
    COMPANY PR0FILE 2021 Delivering New Treatments, Creating Future Smiles Delivering New Treatments, Creating Future Smiles Medicine keeps advancing, but many people around the world still suffer from diseases with no cure. A reliable new drug can bring courage for tomorrow to many patients and their families, and also to every healthcare professional who wants to provide the very best treatment. That’s what drives us to pioneer new methods, work across disciplines, and bring together all of our strengths. Our aim is to offer courage and strength to all who are waiting for new treatments. Our hope is that every day will continue to be vibrant and healthy for everyone for years to come. Creating a future filled with smiles for all. This is our goal at Taiho Pharmaceutical. Corporate We strive to improve human health Philosophy and contribute to a society enriched by smiles. Taiho Pharmaceutical is making diverse contributions to sustainability, always working for better health and more smiles for people around the world. Delivering New Treatments, Creating Future Smiles Medicine keeps advancing, but many people around the world still suffer from diseases with no cure. A reliable new drug can bring courage for tomorrow to many patients and their families, and also to every healthcare professional who wants to provide the very best treatment. That’s what drives us to pioneer new methods, work across disciplines, and bring together all of our strengths. Our aim is to offer courage and strength to all who are waiting for new treatments. Our hope is that every day will continue to be vibrant and healthy for everyone for years to come.
    [Show full text]
  • Otsuka Group Complete Introduction of CO2-Free Electricity for All 23 Manufacturing Facilities in Japan
    June 9, 2021 Otsuka Group Complete Introduction of CO2-free Electricity for All 23 Manufacturing Facilities in Japan - Contributing to a more than 40% reduction in annual CO2 emissions in Japan- Otsuka Holdings Co., Ltd. (Head office: Chiyoda-ku, Tokyo; President and Representative Director, CEO: Tatsuo Higuchi) has completed introduction of CO2-free electricity at all manufacturing facilities of five subsidiary companies in Japan. Derived from renewable energy sources that do not produce CO2 emissions, *1 CO2-free electricity has been introduced at domestic manufacturing facilities of Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Taiho Pharmaceutical Co., Ltd., Otsuka Chemical Co., Ltd., and Otsuka Foods Co., Ltd. The Otsuka group of companies has identified climate change, resource recycling and conservation, and water conservation as important areas (material issues) for environmental initiatives. Regarding climate change, the *2 goal of a 30% global reduction by 2030 is the focus of proactive efforts to reduce CO2 emissions. Adoption of CO2-free electricity at manufacturing facilities, which tend to produce a higher volume of CO2 emissions, began in July 2019. The recent adoption of CO2-free electricity at the Taiho Pharmaceutical Inuyama manufacturing facility in Aichi Prefecture completes the introduction of CO2-free electricity at all 23 manufacturing facilities of five Otsuka subsidiary companies in Japan. In addition to CO2-free electricity, proactive efforts to reduce CO2 emissions include optimization of energy use through adoption of self-consuming solar power generation, cogeneration, and other fuel conversion *3 *4 systems . These combined efforts are predicted to result in a 41% reduction in CO2 emissions during FY2021.
    [Show full text]
  • 2014 Commencement Program
    Emory University The One Hundred Sixty-ninth Commencement The Twelfth of May Two Thousand Fourteen The Alma Mater Table of Contents In the heart of dear old Emory Where the sun doth shine, Order of Exercises .................................................................... 2 That is where our hearts are turning ’Round old Emory’s shrine. Musical Selections .................................................................... 3 Order of Procession ................................................................. 3 We will ever sing thy praises, Award Recipients ..................................................................... 4 Sons and daughters true. Hail we now our Alma Mater, Honorary Degree Recipients .................................................... 6 Hail the Gold and Blue! Diploma Ceremonies ................................................................ 7 Tho’ the years around us gather, Retiring Faculty and Staff ........................................................ 8 Crowned with love and cheer, Still the memory of Old Emory Recipients of Degrees-in-Course ............................................... 9 Grows to us more dear. Emory College of Arts and Sciences ..................................... 9 We will ever sing thy praises, Oxford College .................................................................. 15 Sons and daughters true. School of Medicine ............................................................ 15 Hail we now our Alma Mater, Hail the Gold and Blue! Nell Hodgson Woodruff School of Nursing
    [Show full text]
  • Honouliuli National Monument BY: CAROLE HAYASHINO
    SPRING 2015 | VOL. 21, NO . 1 Honouliuli National Monument BY: CAROLE HAYASHINO Secretary of the Interior Sally Jewell, NPS Deputy Director Peggy O’Dell, Governor and Mrs. David Ige, Senator Mazie Hirono, Mayor Kirk Caldwell, State Senator Will Espero, State Representative Ty Cullen, Consul General of Japan Toyoei Shigeeda, University of “Today I’m announcing three new monuments —places Hawai‘i President David Lassner, along with leaders from Monsanto Hawai‘i, National that reflect our national history and national heritage — Park Service, Japanese American Citizens League, and JCCH to bless the new Honouliuli National Monument on March 31. a new park in my home state of Hawai‘i,” said President Barack Obama on February 19, 2015. “Honouliuli was an internment camp for Japanese Americans during memories of Hawai‘i’s internees, their families, and the thousands World War II. Going forward, it will be a monument to of people who worked and supported the effort to preserve and a painful part of our history so we don’t repeat the protect Honouliuli throughout the years. Jane and I spent our first mistakes of the past.” day visiting the offices of Senator Brian Schatz, Senator Mazie Hirono, Congress Member Tulsi Gabbard and Congress Member We prepared for and anticipated President Obama’s announcement Mark Takai. We are forever grateful to the late Senator Daniel of the new Honouliuli National Monument designation, yet nothing Inouye and owe a debt of gratitude to our congressional delegation could have prepared us for the mix of emotions and whirlwind of for their leadership to preserve Honouliuli.
    [Show full text]
  • How We Will Achieve Sustainability for More Details About Our Health-Related Initiatives, Visit: Health and People
    How we will achieve sustainability For more details about our health-related initiatives, visit: Health and People https://www.otsuka.com/en/csr/society/health/ For more details about our people-related initiatives, visit: As a total healthcare company, the Otsuka group aims to contribute to people’s health as it conducts its https://www.otsuka.com/en/csr/society/people/ business operations. In the pursuit of corporate philosophy, we consider it essential that all employees are able to work freely and vigorously in good health. Therefore, we are promoting proactive measures to enhance employees’ health, while working to resolve health issues through our business operations. Initiatives to Resolve Health Issues Measures to Enhance Employees’ Health Proactively Providing Information and Supporting Various Establishing a workplace where people under treatment can continue Activities - Case of Taiho Pharmaceutical working - Case of Taiho Pharmaceutical Seeking to resolve the unmet medical needs of cancer patients Proactively Providing information Recognizing its employee as precious human resources, Taiho cancer. However, due to the sensitivity of individual experiences, worldwide, Taiho Pharmaceutical promotes the discovery and Pharmaceutical has aimed to establish workplaces where we only have limited occasions to come across its detailed Taiho Pharmaceutical performs proactive activities to communicate development of anticancer agents. It also undertakes diverse other employees under treatment for cancer or other diseases can information.
    [Show full text]